Washington: US pharmaceutical company planned to make at least 600 million doses of its vaccine against COVID-19 in 2021.
Moderna said it planned to produce at least 600 million doses of its vaccine against COVID-19 in 2021, not 500 million as previously announced. In a statement company said, "Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided a supply update for the Moderna COVID-19 Vaccine, increasing its base-case global production estimate from 500 to 600 million doses for 2021." He further said, "Moderna said it is continuing to invest and add staff to build up to potentially 1 billion doses for 2021."
Meanwhile, According to Johns Hopkins University, The overall number of global coronavirus cases has topped 85.6 million, while the deaths have surged to more than 1.85 million. In its latest update on Tuesday morning, the University's Center for Systems Science and Engineering (CSSE) revealed that the current global caseload and death toll stood at 85,637,904 and 1,852,079, respectively.